Low-income, uninsured individuals with multiple cardiovascular risk factors (CRFs) are at risk of heart failure (HF). B-type natriuretic peptide (BNP) screening for asymptomatic left ventricular dysfunction (ALVD) has not been tested specifically in this group. The purposes of this study were to describe BNP levels in asymptomatic low-income, uninsured individuals with multiple CRFs and determine the correlation between BNP levels and echocardiography for identifying ALVD. Methods: This correlational study included 53 patients (age 55 ± 10 years, 83% non-White, 64% female). BNP testing and echocardiogram (ECHO) were performed. Results: Of the 30 patients (57%) diagnosed with ALVD by ECHO, 21 (40%) had diastolic and 9 (17%) systolic dysfunction. BNP levels were lower among those with normal left ventricular (LV) function (29.6 ± 24 pg/mL) than those with diastolic (80.2 ± 69 pg/mL, p = .01) and systolic dysfunction (337.1 ± 374 pg/mL, p = .009). sParticipants with BNP ≥50 pg/ mL were 5.75 times more likely to exhibit diastolic dysfunction (odds ratio [OR] = 5.75, 95% confidence interval [CI] 1.29— 25.51; p < .01) and those with BNP ≥100 pg/mL were 7.80 times more likely to have systolic dysfunction (OR = 7.8, 95% CI 1.60—37.14; p < .005) than those with lower levels. With BNP cut point of 50 pg/mL, area under the curve (AUC) was 0.82 (95% CI 0.63—1.00) with sensitivity of 88% and specificity of 67%. Conclusion: BNP is a low-cost method to detect ALVD in high-risk, uninsured, low-income individuals. Elevated BNP levels should prompt initiation of further diagnostic testing and early treatment.
Alboni, P., Amadei, A., Scarfò, S., Bettiol, K., Ippolito, F., & Baggioni, G. ( 2003). In industrialized nations, a low socioeconomic status represents an independent predictor of mortality in patients with acute myocardial infarction. Italian Heart Journal, 4, 551-558.
2.
Ammar, H., Malani, A.K., Gupta, C., & Dobyan, D.C. ( 2006). Brain natriuretic peptide, clinical reasoning, and congestive heart failure. American Journal of Critical Care, 15, 614-616.
3.
Ayanian, J.Z., Weissman, J.S., Schneider, E.C., Ginsburg, J.A., & Zaslavsky, A.M. (2000). Unmet health needs of uninsured adults in the United States. JAMA, 284, 2061-2069.
4.
Becker, G., Beyene, Y., Newsom, E. M., & Rodgers, D. V. (1998). Knowledge and care of chronic illness in three ethnic minority groups. Family Medicine, 30, 173-178.
5.
Biosite, Inc. (2007). Triage BNP test product insert. San Diego, CA: Author. Retrieved April 27, 2009, from http://www.biosite.com/products/bnp.aspx
6.
Blair, A.S., Lloyd-Williams, F., & Mair, F.S. ( 2002). What do we know about socioeconomic status and congestive heart failure? A review of the literature. Journal of Family Practice, 51, 169.
7.
Burchfiel, C.M., Hamman, R.F., Marshall, J.A., Baxter, J., Kahn, L.B., & Amirani, J.J. ( 1990). Cardiovascular risk factors and impaired glucose tolerance: The San Luis Valley Diabetes Study. American Journal of Epidemiology , 131, 57-70.
8.
Cowie, M.R., Struthers, A.D., Wood, D.A., Coats, A.J., Thompson, S.G., Poole-Wilson, P.A., et al. (1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 350, 1349-1353.
9.
Daniels, L.B., Clopton, P., Bhalla, V., Krishnaswamy, P., Nowak, R.M., McCord, J., et al. (2006). How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly multinational study. American Heart Journal, 151, 999-1005.
10.
Eberhardt, M., Ingram, D., Makuc, D., Pamuk, E.R., Freid, V.M., Harper, S.B., et al. (2001). Urban and rural health chartbook. Health, United States, 2001. Hyattsville, MD: National Center for Health Statistics. Retrieved April 26, 2009, from http://www.cdc.gov/nchs/data/hus/hus01cht.pdf
11.
Flegal, K.M., Ezzati, T.M., Harris, M.I., Haynes, S.G., Juarez, R.Z., Knowler, W.C., et al. (1991). Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care, 14, 628-638.
12.
Goldberg, L.R., & Jessup, M. ( 2006). Stage B heart failure: Management of asymptomatic left ventricular systolic dysfunction. Circulation, 113, 2851-2860.
13.
Haffner, S.M., Hazuda, H.P., Mitchell, B.D., Patterson, J.K., & Stern, M.P. ( 1991). Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care, 14, 102-108.
14.
Hamman, R.F., Marshall, J.A., Baxter, J., Kahn, L.B., Mayer, E.J., Orleans, M., et al. (1989). Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. American Journal of Epidemiology, 129, 295-311.
15.
Heidenreich, P.A., Gubens, M.A., Fonarow, G.C., Konstam, M.A., Stevenson, L.W., & Shekelle, P.G. (2004). Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. Journal of the American College of Cardiology , 43, 1019-1026.
16.
Howie, J.N., Caldwell, M.A., & Dracup, K. ( 2003). The measurement of brain natriuretic peptide in heart failure: Precision, accuracy, and implications for practice. AACN Clinical Issues, 14, 520-531.
17.
Hunt, S.A. ( 2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology , 46, e1-e82.
18.
Krauser, D.G., Lloyd-Jones, D.M., Chae, C.U., Cameron, R., Anwaruddin, S., Baggish, A.L., et al. (2005). Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. American Heart Journal, 149, 744-750.
19.
Krishnaswamy, P., Lubien, E., Clopton, P., Koon, J., Kazanegra, R., Wanner, E., et al. (2001). Utility of B-type natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a veterans hospital . American Journal of Medicine, 111, 274-279.
20.
Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., et al. (2005). Recommendations for chamber quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18, 1440-1463.
21.
Liao, Y., Tucker, P., Okoro, C.A., Giles, W.H., Mokdad, A.H., Harris, V.B., et al. (2004). REACH 2010 surveillance for health status in minority communities-United States, 2001-2002. Morbidity and mortality weekly report. CDC Surveillance Summaries, 53, 1-36.
22.
Lubien, E., DeMaria, A., Krishnaswamy, P., Clopton, P., Koon, J., Kazanegra, R., et al. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation, 105, 595-601.
23.
Maisel, A.S. ( 2003). The diagnosis of acute congestive heart failure: Role of BNP measurements. Heart Failure Review, 8, 327-334.
24.
Maisel, A.S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P., Gardetto, N., et al. (2001). Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. American Heart Journal, 141, 367-374.
25.
Maisel, A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., et al. (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine, 347, 161-167.
26.
McDonagh, T.A. ( 2000). Asymptomatic left ventricular dysfunction in the community . Current Cardiology Report, 2, 470-474.
27.
Mensah, G.A., Mokdad, A.H., Ford, E.S., Greenlund, K.J., & Croft, J.B. ( 2005). State of disparities in cardiovascular health in the United States. Circulation, 111, 1233-1241.
28.
Minutello, R.M., Chou, E.T., Hong, M.K., & Wong, S.C. ( 2006). Impact of race and ethnicity on inhospital outcomes after percutaneous coronary intervention (report from the 2000-2001 New York State Angioplasty Registry). American Heart Journal, 151, 164-167.
29.
Mitchell, B.D., Stern, M.P., Haffner, S.M., Hazuda, H.P., & Patterson, J.K. (1990). Functional impairment in Mexican Americans and non-Hispanic Whites with diabetes. Journal of Clinical Epidemiology, 43, 319-327.
30.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of the High Blood Cholesterol in Adults. (2001). Third report of the NCEP expert panel on detection, evaluation, and treatment of the high blood cholesterol in adults (Adult Treatment Panel III): Executive summary. Retrieved April 30, 2009, from http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3xsum.pdf
31.
Quiñones, M.A., Otto, C.M., Stoddard, M., Waggoner, A., & Zoghbi, W.A. ( 2002). Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography, 15, 167-184.
32.
Rathore, S.S., Masoudi, F.A., Wang, Y., Curtis, J.P., Foody, J.M., Havranek, E.P., et al. (2006). Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: Findings from the National Heart Failure Project. American Heart Journal, 152, 371-378.
33.
Riegel, B., Carlson, B., Glaser, D., & Romero, T. ( 2006). Randomized controlled trial of telephone case management in Hispanics of Mexican origin with heart failure. Journal of Cardiac Failure, 12, 211-219.
34.
Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., et al. (2008). Heart disease and stroke statistics- 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117, e25-e146.
35.
Ross, J.S., Bradley, E.H., & Busch, S.H. ( 2006). Use of health care services by lower-income and higher-income uninsured adults. JAMA, 295, 2027-2036.
36.
Shi, L., & Stevens, G.D. ( 2005). Vulnerability and unmet health care needs. The influence of multiple risk factors. Journal of General Internal Medicine , 20, 148-154.
37.
Shishehbor, M.H., Litaker, D., Pothier, C.E., & Lauer, M.S. ( 2006). Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA, 295, 784-792.
38.
Steptoe, A., Owen, N., Kunz-Ebrecht, S., & Mohamed-Ali, V. (2002). Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain, Behavior, and Immunity, 16, 774-784.
39.
Struthers, A.D., Anderson, G., Donnan, P.T., & MacDonald, T. ( 2000). Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence . Heart, 83, 12-16.
40.
The SOLVD investigators. (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine, 327, 685-691.
41.
U.S. Census Bureau. (2007). Poverty thresholds for 2007 by size of family and number of related children under 18 years. Retrieved April 27, 2009, from http://www.census.gov/hhes/www./poverty/threshld/thresh07.html
42.
Vasan, R.S., Benjamin, E.J., Larson, M.G., Leip, E.P., Wang, T.J., Wilson, P.W., et al. (2002). Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: The Framingham Heart Study. JAMA, 288, 1252-1259.
43.
Wang, T.J., Levy, D., Benjamin, E.J., & Vasan, R.S. ( 2003). The epidemiology of ‘‘asymptomatic’’ left ventricular systolic dysfunction: Implications for screening. Annals of Internal Medicine, 138, 907-916.
44.
Wieczorek, S.J., Wu, A.H., Christenson, R., Krishnaswamy, P., Gottlieb, S., Rosano, T., et al. (2002). A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. American Heart Journal, 144, 834-839.
45.
Winkleby, M., Jatulis, D.E., Frank, E., & Fortmann, S.P. (1992). Socioeconomic status and health: How education, income, and occupation contribute to risk factors for cardiovascular disease. American Journal of Public Health , 82, 816-820.
46.
Yancy, C.W. ( 2004). The prevention of heart failure in minority communities and discrepancies in health care delivery systems. The Medical Clinics of North America, 88, 1347-1368, xii-xiii.
